Clinical nephrologyHumansSodium-Glucose Transporter 2 InhibitorsMaleRenal InsufficiencyChronic
The effect of SGLT2 inhibitor on renal anemia in patients with moderate to severe chronic kidney disease and diabetes.
Chuanlei Li, Jack Kc Ng, Gordon Ck Chan, Winston Ws Fung, Kai-Ming Chow, Cheuk-Chun Szeto
Published: 202610.5414/CN111700
Abstract
BACKGROUND: Sodium glucose cotransporter 2 (SGLT2) inhibitor is a standard treatment for kidney and cardiovascular protection in chronic kidney disease (CKD). Recent evidence suggests that SGLT2 inhibitor may enhance erythropoiesis, but data are limi…
Preview only. Read the full abstract at the source